XORTX Therapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -17 | -25 | -29 | -29 |
EBITDA | -1,672 | -797 | -667 | -686 |
EBIT | -1,690 | -823 | -696 | -716 |
Net Income | -1,690 | -808 | -599 | -649 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,411 | -505 | -726 | -635 |
Cash | 992 | 251 | 864 | 1,193 |
Basic Shares | 1,617 | 1,392 | 1,312 | 971 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -114 | -111 | -141 | -74 |
EBITDA | -3,143 | -3,808 | -5,906 | -12,485 |
EBIT | -3,256 | -3,920 | -6,045 | -12,512 |
Net Income | -2,656 | -3,154 | -2,158 | -10,450 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -2,817 | -3,717 | -6,629 | -9,009 |
Cash | 862 | 2,473 | 3,447 | 10,434 |
Basic Shares | 946 | 575 | 396 | 59 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$1.05 |
2026-03-31 | -$0.58 |
2025-12-31 | -$0.09 |
2025-09-30 | -$1.02 |